If you could vote on Brexit now which option would you choose?
   

India backs AstraZeneca shot as COVID-19 cases hit three-month high


India said on Wednesday its coronavirus immunisation campaign would continue with “full rigour” despite some concerns in Europe about the safety of the AstraZeneca vaccine it relies heavily upon as infections hit a three month high. The European Medicines Agency is investigating reports of 30 cases of unusual blood disorders out of 5 million recipients of the vaccine in the region. Since starting the drive in mid-January, India has administered 36 million vaccine doses, which are mostly the AstraZeneca shots developed with Oxford University and locally known as Covishield.

Reuters - March 17, 2021

View the full story here: https://www.reuters.com/article/us-health-coronavirus-india-cases/indias-coronavirus-infections-rise-by-highest-in-three-months-idUSKBN2B90GS